Chuck Karan, Ph.D., serves as Chief Scientific Officer at Nouveau Biosciences, where he oversees the development of a comprehensive scientific platform spanning drug discovery to clinical trials. Dr. Karan holds a Ph.D. in Organic Chemistry from the University of Rochester. He is a leader in novel assay and technology development, contributing to both academic and biotech sectors. At Columbia Medical Center, Chuck led the High-Throughput Screening Facility, where he spearheaded the creation of an automated transcriptomic platform now adopted by research hospitals for accelerating biological systems analysis. His leadership drove the development of innovative tools that directly improved patient outcomes. This extensive experience in building and managing multi-disciplinary teams and pioneering automation technologies informs his strategic direction at Nouveau Biosciences, ensuring the organization remains at the forefront of scientific innovation.